These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28483660)

  • 1. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes.
    Isgren A; Sellgren C; Ekman CJ; Holmén-Larsson J; Blennow K; Zetterberg H; Jakobsson J; Landén M
    Brain Behav Immun; 2017 Oct; 65():195-201. PubMed ID: 28483660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.
    Jakobsson J; Bjerke M; Sahebi S; Isgren A; Ekman CJ; Sellgren C; Olsson B; Zetterberg H; Blennow K; Pålsson E; Landén M
    J Psychiatry Neurosci; 2015 Jul; 40(4):250-8. PubMed ID: 25768030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.
    Johansson V; Jakobsson J; Fortgang RG; Zetterberg H; Blennow K; Cannon TD; Hultman CM; Wetterberg L; Landén M
    Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):391-402. PubMed ID: 28039552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
    Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
    J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.
    Rolstad S; Jakobsson J; Sellgren C; Isgren A; Ekman CJ; Bjerke M; Blennow K; Zetterberg H; Pålsson E; Landén M
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1091-8. PubMed ID: 26024928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.
    Jakobsson J; Bjerke M; Ekman CJ; Sellgren C; Johansson AG; Zetterberg H; Blennow K; Landén M
    Neuropsychopharmacology; 2014 Sep; 39(10):2349-56. PubMed ID: 24694925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.
    Bai YM; Su TP; Tsai SJ; Wen-Fei C; Li CT; Pei-Chi T; Mu-Hong C
    J Affect Disord; 2014 Sep; 166():187-92. PubMed ID: 25012430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
    Kwon BK; Stammers AM; Belanger LM; Bernardo A; Chan D; Bishop CM; Slobogean GP; Zhang H; Umedaly H; Giffin M; Street J; Boyd MC; Paquette SJ; Fisher CG; Dvorak MF
    J Neurotrauma; 2010 Apr; 27(4):669-82. PubMed ID: 20038240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.
    Judd LL; Akiskal HS; Schettler PJ; Endicott J; Leon AC; Solomon DA; Coryell W; Maser JD; Keller MB
    Arch Gen Psychiatry; 2005 Dec; 62(12):1322-30. PubMed ID: 16330720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral inflammatory markers associated with brain volume reduction in patients with bipolar I disorder.
    Tsai SY; Sajatovic M; Hsu JL; Chung KH; Chen PH; Huang YJ
    Acta Neuropsychiatr; 2022 Aug; 34(4):191-200. PubMed ID: 34924065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.
    Rolstad S; Jakobsson J; Sellgren C; Ekman CJ; Blennow K; Zetterberg H; Pålsson E; Landén M
    PLoS One; 2015; 10(5):e0127100. PubMed ID: 25954806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
    Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
    Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis.
    Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; ; Engberg G; Erhardt S
    Acta Psychiatr Scand; 2018 Nov; 138(5):432-440. PubMed ID: 30132802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.
    Söderlund J; Olsson SK; Samuelsson M; Walther-Jallow L; Johansson C; Erhardt S; Landén M; Engberg G
    J Psychiatry Neurosci; 2011 Mar; 36(2):114-8. PubMed ID: 21138659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.
    Olsson SK; Sellgren C; Engberg G; Landén M; Erhardt S
    Bipolar Disord; 2012 Nov; 14(7):719-26. PubMed ID: 23030601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
    Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
    Psychiatry Res; 2017 Jan; 247():105-112. PubMed ID: 27886578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients.
    Munkholm K; Weikop P; Kessing LV; Vinberg M
    Brain Behav Immun; 2015 Jan; 43():205-13. PubMed ID: 25451609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment.
    Isgren A; Jakobsson J; Pålsson E; Ekman CJ; Johansson AG; Sellgren C; Blennow K; Zetterberg H; Landén M
    Brain Behav Immun; 2015 Jan; 43():198-204. PubMed ID: 25451615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
    Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
    Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.